Bone Marrow Transplantation News

Three physicians have been elected to serve in leadership roles on ASH’s executive committee.

The FDA announced several regulatory actions.

President Joe Biden today announced his intention to appoint oncologist, researcher and educator, W. Kimryn Rathmell, MD, PhD, as director of the NCI.

Bioengineering company Ossium Health, which is developing the first bank of bone marrow collected from organ donors, has partnered with the National Marrow Donor Program/Be The Match to increase access to lifesaving bone marrow.

This blog post provides answers to important questions about the upcoming respiratory viral seasons.

The FDA approved motixafortide combined with filgrastim for mobilization of hematopoietic stem cells into peripheral blood during collection for subsequent autologous transplantation in individuals with multiple myeloma.

Marcel van den Brink, MD, PhD, has been appointed president of City of Hope Los Angeles and National Medical Center.

When I was young, green and fresh out of school, I got a job as a clinical social worker in an adult bone marrow transplant program.

A pathfinder spaceflight investigation has flown to the International Space Station with a goal of expanding a population of hematopoietic stem cells that retain their multipotency.

Younger patients with diverse gut microbiota prior to allogeneic hematopoietic stem cell transplantation had a significantly lower risk for death following the procedure than those with low diversity, according to study results.